Skip to main contentAI and Advanced
/
MEDPLUS · NSEBSE SENSEX74,314.59-0.03%BSE |
NIFTY 5023,270.6+0.23%NSE |
NIFTY BANK56,055.75-0.42%NSE |
NIFTY IT29,155.6+0.23%NSE |
NIFTY AUTO27,159.15+0.99%NSE |
NIFTY FMCG45,572.7+0.03%NSE |
NIFTY PHARMA26,579.25+1.66%NSE |
NIFTY 50022,654.65+0.54%NSE |
ME
NSE · Equity shares · Retail (Drugs)-0.25 · -0.04%
MedPlus Health Services MEDPLUS
NSE:INR 653.75
BSE:INR 655.1
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for MEDPLUS
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 654
Day rangeINR 652 — INR 669
52-week rangeINR 645 — INR 1,022.2
Volume1.22 L
Market cap8,266.75
P/E46.19
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)6,892.47
Net Income (INR Cr)219.65
Rev Growth (5 Year %)17.56
EPS Growth (5 Year %)27.86
P/E Ratio46.19
EPS18.11
Research path: Interpret MedPlus Health Services's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
MEDPLUSMedPlus Health Services1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 3,932.53 | 3,360.1 | 3,004.8 |
| Accumulated Depreciation Total | -949.39 | -742.92 | -612.08 |
| Cash Equivalents | 154.95 | 44.08 | 42.62 |
| Other Liabilities Total | 35.46 | 35.59 | 33.42 |
| Accrued Expenses | 120.89 | 114.23 | 92.75 |
| Common Stock Total | 24.01 | 23.94 | 23.91 |
| Other Current Assets Total | 3.08 | 3.12 | 3.07 |
| Prepaid Expenses | 15.25 | 12.08 | 9.85 |
| Total Assets | 3,932.53 | 3,360.1 | 3,004.8 |
| Current Portof LT Debt/Capital Leases | 191.26 | 111.79 | 141.49 |
| Additional Paid-In Capital | 1,255.37 | 1,224.63 | 1,208.65 |
| Cash | 43.46 | 41.97 | 48.59 |
| Total Equity | 1,975.36 | 1,740.56 | 1,577.93 |
| Long Term Investments | 1.7 | 2.36 | 5.1 |
| Retained Earnings(Accumulated Deficit) | 695.98 | 491.99 | 345.37 |
| Total Common Shares Outstanding | 12.01 | 11.97 | 11.95 |
| Property/Plant/Equipment Total-Gross | 2,526.58 | 2,004.69 | 1,813.47 |
| Tangible Book Valueper Share Common Eq | 160.43 | 141.17 | 127.69 |
| Goodwill Net | 41.45 | 41.45 | 41.45 |
| Total Liabilities | 1,957.17 | 1,619.53 | 1,426.87 |
| Total Debt | 1,424.38 | 1,119.8 | 1,009.57 |
| Short Term Investments | 394.05 | 353.8 | 73.83 |
| Cashand Short Term Investments | 592.46 | 439.85 | 165.04 |
| Total Receivables Net | 62.54 | 26.99 | 28.2 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Accounts Receivable-Trade Net | 26.96 | 13.27 | 17.52 |
| Property/Plant/Equipment Total-Net | 1,577.18 | 1,261.75 | 1,201.38 |
| Minority Interest | -0.71 | -0.66 | -0.57 |
| Total Current Liabilities | 689.29 | 576.59 | 525.94 |
| Total Inventory | 1,395.32 | 1,361.47 | 1,361.4 |
| Accounts Payable | 306.95 | 298.96 | 253.04 |
| Other Currentliabilities Total | 70.19 | 51.61 | 38.67 |
| Total Long Term Debt | 1,233.12 | 1,008.01 | 868.08 |
| Intangibles Net | 7.88 | 9.44 | 10.08 |
| Other Long Term Assets Total | 224.61 | 190.18 | 163.32 |
| Note Receivable-Long Term | 11.07 | 11.4 | 15.92 |
| Total Current Assets | 2,068.65 | 1,843.52 | 1,567.55 |
| Capital Lease Obligations | 1,233.12 | 1,008.01 | 868.08 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.62
Price to Sale Ratio1.20
Growth
Debt 5Yr CAGR %19.27
Margins
Operating Margin 12m4.35
Operating Margin 5y Avg3.49
Net Profit Margin 12m2.91
Net Profit Margin 5y2.15
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk34.77
Analyst consensus
ConsensusStrong Buy
Consensus score1.33
Analyst opinions6
Strong Sell count0
Sell count0
Hold count0
Buy count2
Strong Buy count4
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Novelix Pharmaceuticals | INR 73.8 | 201.57 | 52.28 | — |
| Muller & Phipps India Ltd | INR 218 | 13.63 | Not available | — |
Shareholding
Ownership
- Promoter
- 40.19%
- FII
- 14.38%
- MF
- 24.51%
- Other
- 20.92%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
MedPlus Shares Fall Over 17% After Q1 Net Profit Declines 21% - NDTV ProfitMarket news · 22 Jul 2026, 9:52 am
MedPlus Shares Fall Over 17% After Q1 Net Profit Declines 21% NDTV Profit
Medplus Health Services Ltd Hits Intraday Low Amid Price Pressure - MarketsMojoMarket news · 22 Jul 2026, 9:42 am
Medplus Health Services Ltd Hits Intraday Low Amid Price Pressure MarketsMojo
Medplus Health Services consolidated net profit declines 21.67% in the June 2026 quarter - Business StandardMarket news · 22 Jul 2026, 9:05 am
Medplus Health Services consolidated net profit declines 21.67% in the June 2026 quarter Business Standard
MedPlus Health's Q1 profit falls 22 pc to Rs 33 crore - The Hans IndiaMarket news · 21 Jul 2026, 9:50 pm
MedPlus Health's Q1 profit falls 22 pc to Rs 33 crore The Hans India
MedPlus Q1FY27 net profit rises 4.6% to ₹331.67 million - scanx.tradeMarket news · 21 Jul 2026, 9:14 pm
MedPlus Q1FY27 net profit rises 4.6% to ₹331.67 million scanx.trade
MedPlus Health Q1 Profit Drops 22% as Expenses Rise - WhalesbookMarket news · 21 Jul 2026, 8:18 pm
MedPlus Health Q1 Profit Drops 22% as Expenses Rise Whalesbook
Corporate actions
Events
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsAudited Results
- board Meetings(Revised)
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
Rusaka Markets Community
Discussion and sentiment for MedPlus Health Services
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
MedPlus Health Services Limited is an India-based company. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through three segments: Retail, Diagnostics, and Others. The Retail segment is engaged in trading pharmaceuticals and general items through its retail stores and online platform. The Diagnostics segment includes diagnostic services, pathological services, and laboratory testing services. The other segment includes the insurance broking business. Its products include Pharmaceutical and wellness products and Fast-moving consumer goods (FMCG). Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its e-commerce portals include MedPlus Mart, MedPlus Lens, and MedPlus Labs.
Company facts
- Industry
- Retail (Drugs)
- Sector
- Retail (Drugs)
- NSE Code
- MEDPLUS
- BSE Code
- 543427
Questions
Stock FAQ
What is the symbol and ISIN of MedPlus Health Services?
MedPlus Health Services has the symbol MEDPLUS and ISIN - INE804L01022.
What is the current price of MedPlus Health Services?
MedPlus Health Services is currently trading at INR 653.75.
What are the year high and year low of MedPlus Health Services?
MedPlus Health Services has a year high of INR 1,022.20 and a year low of INR 645.00.
What is the market capitalization of MedPlus Health Services?
MedPlus Health Services has a market capitalization of INR 8,266.75 crore.
What is the P/E ratio of MedPlus Health Services?
MedPlus Health Services has a P/E ratio of 46.19.
What is the dividend yield of MedPlus Health Services?
MedPlus Health Services has a dividend yield of 0.00%.
How is the financial performance of MedPlus Health Services based on revenue, net income, and EPS?
MedPlus Health Services has revenue of INR 6,892.47 crore, net income of INR 219.65 crore, and EPS of INR 17.52.
What is the book value of MedPlus Health Services?
MedPlus Health Services has a book value of NA.
What is the debt-to-equity ratio of MedPlus Health Services?
MedPlus Health Services has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of MedPlus Health Services?
MedPlus Health Services has a price-to-book ratio of NA and a price-to-sales ratio of 1.20.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.